On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Amvac Research GmbH's own share of each project, not the project's full budget.
- FP7 (2007 to 2013)€469k · 1 project
Projects
1 EU-funded project, newest first. Each links to the official record.
- UniVaxPartner
A “Universal” Influenza Vaccine through Synthetic, Dendritic Cell-Targeted, Self-Replicating RNA Vaccines
FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗
€469ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Centre National de la Recherche Scientifique CNRSFrance · 1 shared project
- The University of ManchesterUnited Kingdom · 1 shared project
- Universitetet i BergenNorway · 1 shared project
- Helmholtz-Zentrum Fur Infektionsforschung GmbHGermany · 1 shared project
- Eidgenoessisches Departement des InnernSwitzerland · 1 shared project
- Tp21 GmbHGermany · 1 shared project
- Oz Biosciences SASFrance · 1 shared project
- Meditox S.r.oCzech Republic · 1 shared project
- Vitamfero SAFrance · 1 shared project
- Synthaur OooRussia · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- RNA
- carbohydrates
- immunology
- influenza
- vaccines
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗